{"entity":{"id":"nct00006371","kind":"trial","name":"A Phase II Trial of Early Medical Adrenalectomy for \"D0.5\" Prostate Cancer","aka":[],"tldr":"A phase 2 trial of Aminoglutethimide in Prostate cancer, run by H. Lee Moffitt Cancer Center and Research Institute, recorded as terminated on the registry.","summary":"A Phase II Trial of Early Medical Adrenalectomy for \"D0.5\" Prostate Cancer is a phase 2 interventional study registered as NCT00006371 by H. Lee Moffitt Cancer Center and Research Institute, with 2 participants recorded, started 2000-05 and due to reach its primary completion in 2001-12. Interventions recorded: aminoglutethimide, ketoconazole, therapeutic hydrocortisone. Conditions recorded: Prostate Cancer.\n\nLinked to the drug Aminoglutethimide because the registry names it among its interventions and Prostate cancer among its conditions. Registry record only: no result has been read by an editor.","asOf":"2026-09-22","links":[{"label":"ClinicalTrials.gov NCT00006371","url":"https://clinicaltrials.gov/study/NCT00006371"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["prostate"],"sections":[],"technologies":[],"targets":[],"drugs":["aminoglutethimide"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT00006371","phase":"2","setting":"A Phase II Trial of Early Medical Adrenalectomy for \"D0.5\" Prostate Cancer","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","enrolled":2,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct00006371/","neighbours":{"cancer":[{"id":"prostate","kind":"cancer","name":"Prostate cancer","route":"/cancers/prostate/"}],"drug":[{"id":"aminoglutethimide","kind":"drug","name":"Aminoglutethimide","route":"/drugs/aminoglutethimide/"}]}}